Literature DB >> 33946653

Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease.

Francisco Herrera-Gómez1,2,3, F Javier Álvarez3.   

Abstract

The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entitled "Biomarkers in Chronic Kidney Disease", with the intention to identify high-risk patients. These markers do not target measurable parameters in patients but clinical endpoints that may be in turn transformed to benefits under the effect of future interventions.

Entities:  

Keywords:  biomarkers; chronic kidney disease; real-world evidence

Year:  2021        PMID： 33946653     DOI： 10.3390/biomedicines9050488

Source DB:  PubMed          Journal:  Biomedicines        ISSN： 2227-9059


  13 in total

1.  Longitudinal progression trajectory of GFR among patients with CKD.

Authors:  Liang Li; Brad C Astor; Julia Lewis; Bo Hu; Lawrence J Appel; Michael S Lipkowitz; Robert D Toto; Xuelei Wang; Jackson T Wright; Tom H Greene
Journal:  Am J Kidney Dis       Date:  2012-01-26       Impact factor: 8.860

2.  Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).

Authors:  Ivan Formentini; Maria Bobadilla; Carolina Haefliger; Guido Hartmann; Mahmoud Loghman-Adham; Jacques Mizrahi; Silvia Pomposiello; Marco Prunotto; Matthias Meier
Journal:  Nephrol Dial Transplant       Date:  2012-06-25       Impact factor: 5.992

3.  Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.

Authors:  Jane P F Bai; Robert Bell; ShaAvhree Buckman; Gilbert J Burckart; Hans-Georg Eichler; Kenneth C Fang; Federico M Goodsaid; William J Jusko; Lawrence L Lesko; Bernd Meibohm; Scott D Patterson; Oscar Puig; Jeffrey B Smerage; Barbara J Snider; John A Wagner; Jingsong Wang; Marc K Walton; Russell Weiner
Journal:  AAPS J       Date:  2011-03-30       Impact factor: 4.009

4.  A composite score associated with spontaneous operational tolerance in kidney transplant recipients.

Authors:  Richard Danger; Mélanie Chesneau; Chloé Paul; Pierrick Guérif; Maxim Durand; Kenneth A Newell; Sai Kanaparthi; Laurence A Turka; Jean-Paul Soulillou; Rémi Houlgatte; Magali Giral; Gérard Ramstein; Sophie Brouard
Journal:  Kidney Int       Date:  2017-02-24       Impact factor: 10.612

Review 5.  Biomarkers in chronic kidney disease: a review.

Authors:  Robert G Fassett; Sree K Venuthurupalli; Glenda C Gobe; Jeff S Coombes; Matthew A Cooper; Wendy E Hoy
Journal:  Kidney Int       Date:  2011-06-22       Impact factor: 10.612

6.  A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.

Authors:  Daniel Baron; Gérard Ramstein; Mélanie Chesneau; Yann Echasseriau; Annaick Pallier; Chloé Paul; Nicolas Degauque; Maria P Hernandez-Fuentes; Alberto Sanchez-Fueyo; Kenneth A Newell; Magali Giral; Jean-Paul Soulillou; Rémi Houlgatte; Sophie Brouard
Journal:  Kidney Int       Date:  2015-01-28       Impact factor: 10.612

7.  The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies.

Authors:  Coralina Bernuy-Guevara; Hassib Chehade; Yannick D Muller; Julien Vionnet; François Cachat; Gabriella Guzzo; Carlos Ochoa-Sangrador; F Javier Álvarez; Daniel Teta; Débora Martín-García; Marcel Adler; Félix J de Paz; Frank Lizaraso-Soto; Manuel Pascual; Francisco Herrera-Gómez
Journal:  Biomedicines       Date:  2020-09-16

8.  Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease.

Authors:  Ashani Lecamwasam; Tiffanie M Nelson; Leni Rivera; Elif I Ekinci; Richard Saffery; Karen M Dwyer
Journal:  Biomedicines       Date:  2020-12-29

9.  Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD.

Authors:  Elena Dozio; Simone Vettoretti; Lara Caldiroli; Silvia Nerini-Molteni; Lorenza Tacchini; Federico Ambrogi; Piergiorgio Messa; Massimiliano M Corsi Romanelli
Journal:  Biomedicines       Date:  2020-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.